1. Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012 Feb; 36(1): 56 - 9.
2. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet, 2010, 21; 376(9741): 631 - 442.
3. ВОЗ. Материнская смертность. Информационный бюллетень N 348. Май 2012 г. http://www.who.int/mediacentre/factsheets/fs348/ru/index.html.
4. Стародубов В.И., Суханова Л.П. Репродуктивные проблемы демографического развития России. М.: ИД "Менеджер здравоохранения"; 2012. - 320 с.
5. Основные показатели деятельности службы охраны здоровья матери и ребенка в Российской Федерации. Статистическая форма 32 за 2012 год. Авторы-составители: Э.Е. Запорожец, М.П. Шувалова, Л.М. Цымлякова, О.Г. Фролова, Е.В. Огрызко, Л.П. Суханова. Российское общество акушеров-гинекологов. ФГБУ "НЦАГИП им. В.И. Кулакова" Минздрава России. ФГБУ "ЦНИИОИЗ" Минздрава России. Москва. 2013. с. 48 - 50, 59 - 61.
6. Young B., Hacker M.R., Rana S.PHYSICIANS" KNOWLEDGE OF FUTURE VASCULAR DISEASE IN WOMEN WITH PREECLAMPSIA Hypertens Pregnancy. 2012; 31(1): 50 - 58. doi:10.3109/10641955.2010.544955.
7. Barton JR, Barton LA, Istwan NB, et al. Elective delivery at 340/7 to 366/7 weeks" gestation and its impact on neonatal outcomes in women with stable mild gestational hypertension. American Journal of Obstetrics and Gynecology. 2011; 204(1): 44.e1 - 44.e5.
8. Andersgaard AB, Acharya G, Mathiesen EB, et al. Recurrence and long-term maternal health risks of hypertensive disorders of pregnancy: a population-based study. Am J Obstet Gynecol 2011; 205.
9. Савельева Г.М. с соавт. Эклампсия в современном акушерстве, Акушерство и гинекология, 2010, N 6. 4 - 9.
10. Magee LA, Helewa M, Moutquin JM, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Journal of obstetrics and gynaecology Canada: JOGC = Journal d"obstetrique et gynecologie du Canada: JOGC. Mar 2008; 30(3 Suppl): S1 - 48.
11. RCOG. Guideline No. 10(A). The Management of Severe Preeclampsia/Eclampsia 2010.
12. Макаров О.В., Ткачева О.Н., Волкова Е.В. Преэклампсия и хроническая артериальная гипертензия, Клинические аспекты. М.: ГЭОТАР-Медиа; 2010
13. Eiland E., Nzerue C., Faulkner, Faulkner M Preeclampsia 2012, J Pregnancy. 2012; 2012: 586578. Published online 2012 July 11.
14. Chappal LC, Enye St. Seed P, Briley AL, Poston L, Shennan AH: Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 2008; 51: 1002 - 9
15. Karumanchi SA, Lindheimer MD: Advances in Understanding of eclampsia. Current Hypertension Reports 2008; 10: 305 - 12.
16. GAIN. Management of Severe Pre-eclampsia and Eclampsia. Guidelines and Audit Implementation Network; 2012 March
17. Meler E, Figueras F, Bennasar M, Gomez O, Crispi F, Gratacos E. The prognostic role of uterine artery Doppler investigation in patients with severe early-onset preeclampsia. American journal of obstetrics and gynecology. Jun 2010; 202(6): 559 e551 - 554.
18. Giguere Y, Charland M, Bujold E, et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clinical chemistry. Mar 2010; 56(3): 361 - 375.
19. Di Lorenzo G, Ceccarello M, Cecotti V, Ronfani L, Monasta L, Vecchi Brumatti L, Montico M, D"Ottavio G. First trimester maternal serum PIGF, free-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta. 2012 Jun; 33(6): 495 - 501. doi: 10.1016/j.placenta.2012.03.003. Epub 2012 Mar 28.
20. Barton JR, Sibai BM. Prediction and prevention of recurrent preeclampsia. Obstetrics and gynecology. Aug 2008; 112(2 Pt 1): 359 - 372.
21. Towner D, Gandhi S, El Kady D. Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin. American journal of obstetrics and gynecology. Jun 2006; 194(6): 1676 - 1681; discussion 1681 - 1672.
22. A, Campos-Galicia I, Isordia-Salas I, Rivera-R, Romero-Arauz JF, Ayala-JA, Ulloa-Aguirre A. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia. J Hypertens. 2012 Nov; 30(11): 2173 - 81. doi: 10.1097/HJH.0b013e328357c0c9.
23. Kanasaki K, Kalluri R. The biology of preeclampsia. Kidney international. Oct 2009; 76(8): 831 - 837.
24. Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ (Clinical research ed.). Oct 15 2005; 331(7521): 877.
25. Cha J, Sun X, Dey SK. Mechanisms of implantation: strategies for successful pregnancy. Nat Med. 2012 Dec; 18(12): 1754 - 67. doi: 10.1038/nm.3012. Review.
26. Roberge S, Y, Villa P, Nicolaides K, Vainio M, Forest JC, von Dadelzen P, Vaiman D, Tapp S, Bujold E. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and metaanalysis. Am J Perinatol. 2012 Aug; 29(7): 551 - 6. doi: 10.1055/S-0032-1310527. Epub 2012 Apr 11.
27. Valenzuela F., P"erez-Sepulveda A., Torres M.J., Correa P., Repetto G.M., etal Pathogenesis of Preeclampsia: The Genetic Component. Review Article. Journal of Pregnancy Volume 2012, Article ID 632732, 8 pages doi:10. 1155/2012/632732.
28. Hofmeyr GJ, Lawrie TA, Atallah BN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews, 2010, (8): CD001059.
29. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. The Journal of clinical endocrinology and metabolism. Jan 2011; 96(1): 53 - 58.
30. Imdad A, Jabeen A, Bhutta ZA. Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries. BMC public health. 2011; 11 Suppl 3: S18
31. De Regil LM, Palacios C, Ansary A, Kulier R, Peca-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database of Systematic Reviews, 2011.
32. World Health Organization. WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia. Geneva; 2011. - 38 с
33. Churchill D, Beevers GD, Meher S, Rhodes C. Diuretics for preventing preeclampsia. Cochrane database of systematic reviews (Online). 2007(1): CD004451.
34. Mello G, Parretti E, Fatini C, et al. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension. Jan 2005; 45(1): 86 - 91.
35. Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane database of systematic reviews (Online). 2008(1): CD004227.
36. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. Cochrane database of systematic reviews (Online). 2006(3): CD003402.
37. Meher S, Duley L. Garlic for preventing pre-eclampsia and its complications. Cochrane database of systematic reviews (Online). 2006(3): CD006065.
38. Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Low sodium diet and pregnancy-induced hypertension: a multi-centre randomised controlled trial. British journal of obstetrics and gynaecology. Apr 1998; 105(4): 430 - 434.
39. ACOG Practice Bulletin No. 125: Chronic hypertension in pregnancy. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2012 Feb; 119(2 Pt 1): 396 - 407. doi: 10.1097/AOG.0b013e318249ff06.
40. РМОАГ. Диагностика и лечение артериальной гипертонии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов 2008: 32.
41. Cote AM, Firoz T, Mattman A, Lam EM, von Dadelszen P, Magee LA. The 24-hour urine collection: gold standard or historical practice? American journal of obstetrics and gynecology. Dec 2008; 199(6): 625 e621 - 626.
42. Thangaratinam S, Coomarasamy A, O"Mahony F, et al. Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review. BMC medicine. 2009; 7: 10.
43. Lindheimer MD, Kanter D. Interpreting abnormal proteinuria in pregnancy: the need for a more pathophysiological approach. Obstetrics and gynecology. Feb 2010; 115(2 Pt 1): 365 - 375.
44. Cote AM, Brown MA, Lam E, et al. Diagnostic accuracy of urinary spot protein:creatinine ratio for proteinuria in hypertensive pregnant women: systematic review. BMJ (Clinical research ed.). May 3 2008; 336(7651): 1003 - 1006.
45. Morris RK, Riley RD, Doug M, Deeks JJ, Kilby MD. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. BMJ (Clinical research ed.). 2012; 345: e4342.
46. Milne F, Redman C, Walker J, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ (Clinical research ed.). Mar 12 2005; 330(7491): 576 - 580.
47. NICE. Clinical Guideline: Hypertension in pregnancy. The management of hypertensive disorders during pregnancy 2010.
48. Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks" gestation. American journal of obstetrics and gynecology. Sep 2011; 205(3): 191 - 198.
49. Sidhu H. Pre-eclampsia and Eclampsia. In: Johanson R, Cox C, Grady K, Howell C, eds. Managing Emergencies and Trauma: The MOET Course Manual. London: RCOG Press; 2003: 133 - 147.
50. Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ (Clinical research ed.). Nov 26 1994; 309(6966): 1395 - 1400.
51. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy and Childbirth, 2009, 9: 8
52. Abildgaard U., Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol. 2013 Feb: 166(2): 117 - 23.
53. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy, SOGC CLINICAL PRACTICE GUIDELINE, No. 206 March 2008
54. Сухих Г.Т., Ткачева О.Н., (п/ред) Диагностика и лечение артериальной гипертонии у беременных. М.: Миклош; 2011.
55. Стрюк Р.И., Брыткова Я.В., Бухонкина Ю.М. Клиническая эффективность антигипертензивной терапии пролонгированным нифедипином и бисопрололом беременных с артериальной гипертонией. Кардиология. 2008; 48(4): 29 - 33.
56. Рунихина Н.К. Ткачева О.Н., Ходжаева З.С. и соавт.: Диагностика и лечение артериальной гипертонии у беременных//Акушерство и гинекология, 2012, специальный выпуск, с. 51 - 54.
57. Thompson JL, Kuller JA, Rhee EH. Antenatal surveillance of fetal growth restriction. Obstet Gynecol Surv. 2012 Sep; 67(9): 554 - 65. doi: 10.1097/OGX.0b013e31826a5c6f. Review.
58. GRIT. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG: an international journal of obstetrics and gynaecology. Jan 2003; 110(1): 27 - 32.
59. RCOG. Guideline No. 7. Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality 2010
60. Duley L, AM, Henderson-Smart DJ, Chou D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane database of systematic reviews (Online). 2010(11): CD000025.
61. Cantwell R, Clutton-Brock T, Cooper G, et al. Saving Mothers" Lives: Reviewing maternal deaths to make motherhood safer: 2006 - 2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG: an international journal of obstetrics and gynaecology. Mar 2011; 118 Suppl 1: 1 - 203.
62. Ganzevoort W, Rep A, Bonsel GJ, Fetter WP, van Sonderen L, De Vries JI, Wolf H; PETRA investigators. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia. BJOG. 2005 Oct; 112(10): 1358 - 68.
63. Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks" gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. Sep 19 2009; 374(9694): 979 - 988.
64. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Regional anesthesia and pain medicine. May - Jun 2003; 28(3): 172 - 197.
65. Moore TR, Key TC, Reisner LS, Resnik R. Evaluation of the use of continuous lumbar epidural anesthesia for hypertensive pregnant women in labor. American journal of obstetrics and gynecology. Jun 15 1985; 152(4): 404 - 412.
66. Cooper GM, McClure JH. Maternal deaths from anaesthesia. An extract from Why Mothers Die 2000 - 2002, the Confidential Enquiries into Maternal Deaths in the United Kingdom: Chapter 9: Anaesthesia. British journal of anaesthesia. Apr 2005; 94(4): 417 - 423.
67. Aya AG, Vialles N, Tanoubi I, et al. Spinal anesthesia-induced hypotension: a risk comparison between patients with severe preeclampsia and healthy women undergoing preterm cesarean delivery. Anesthesia and analgesia. Sep 2005; 101(3): 869 - 875, table of contents.
68. YOO KY, Jeong CW, Park BY, et al. Effects of remifentanil on cardiovascular and bispectral index responses to endotracheal intubation in severe pre-eclamptic patients undergoing Caesarean delivery under general anaesthesia. British journal of anaesthesia. Jun 2009; 102(6): 812 - 819.
69. Su LL, Rauff M, Chan YH, Mohamad Suphan N, Lau TP, Biswas A, Chong YS. Carbetocin versus syntometrine for the third stage of labour following vaginal delivery-a double-blind randomised controlled trial. BJOG. 2009 Oct; 116(11): 1461 - 6
70. Belghiti J, Kayem G, Tsatsaris V, Goffinet F., Sibai B., Haddad B.: Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction. Am J Obstet Gynecol 2011; 205: 465.e1 - 6.
71. Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database of Systematic Reviews 2010, Issue 9. Art. No.: CD008148. DOI: 10.1002/14651858. CD008148.pub2.
72. Clenney TL, Viera AJ. Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome. BMJ (Clinical research ed.). Jul 31 2004; 329(7460): 270 - 272.
73. RCOG. Guideline No. 37a. Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium. Vol 37a2009.
74. Beckmann CRB, Ling FW, Barzansky BM, etc. Obstetrics and Gynecology. Sixth Edition ed: ACOG; 2010.
75. Magee LA, Yong PJ, Espinosa V, Cфtй AM, Chen I, von Dadelszen P. Expectant management of severe pre-eclampsia remote from term: a structured systematic review. Hypertension in Pregnancy, 2009, (3): 312 - 347.
76. Andersgaard A.B., Acharya G., Mathiesen E.B., Johnsen S.H., Straume B., ian P. Recurrence and long-term maternal health risks of hypertensive disorders of pregnancy: a population-based study Am J Obstet Gynecol 2011; 205:
- Гражданский кодекс (ГК РФ)
- Жилищный кодекс (ЖК РФ)
- Налоговый кодекс (НК РФ)
- Трудовой кодекс (ТК РФ)
- Уголовный кодекс (УК РФ)
- Бюджетный кодекс (БК РФ)
- Арбитражный процессуальный кодекс
- Конституция РФ
- Земельный кодекс (ЗК РФ)
- Лесной кодекс (ЛК РФ)
- Семейный кодекс (СК РФ)
- Уголовно-исполнительный кодекс
- Уголовно-процессуальный кодекс
- Производственный календарь на 2023 год
- МРОТ 2024
- ФЗ «О банкротстве»
- О защите прав потребителей (ЗОЗПП)
- Об исполнительном производстве
- О персональных данных
- О налогах на имущество физических лиц
- О средствах массовой информации
- Производственный календарь на 2024 год
- Федеральный закон "О полиции" N 3-ФЗ
- Расходы организации ПБУ 10/99
- Минимальный размер оплаты труда (МРОТ)
- Календарь бухгалтера на 2024 год
- Частичная мобилизация: обзор новостей